
Health Care
Cipla Strengthens Diabetes and Obesity Portfolio with Launch of Yurpeak® (Tirzepatide)
Mangalore 7th Jan 2025: Cipla Limited (BSE: 500087; NSE: CIPLA; and hereafter referred to as “Cipla”) today announced the

Mangalore 7th Jan 2025: Cipla Limited (BSE: 500087; NSE: CIPLA; and hereafter referred to as “Cipla”) today announced the

Bengaluru, January 7th, 2026 Avtar Group, India’s leading workplace culture consulting firm, released the fourth edition of its annual,